RESEARCHER PROFILE
Associate Professor Tasha Stanton, (Filmed May 2024)
Associate Professor of Clinical Pain Neuroscience
SAHMRI (South Australian Health and Medical Research Institute) & University of South Australia, Adelaide, South Australia
Associate Professor Tasha Stanton leads the Persistent Pain Research Group at SAHMRI. She is also co-Director of IIMPACT in Health at the University of South Australia, Adelaide. She is a clinical pain neuroscientist, with original training as a physiotherapist, and her research focusses on pain – why do we have it and why doesn’t it go away? She has received over $7.3m in competitive research funding, including fellowships from the Canadian Institute for Health Research and the National Health & Medical Research Council (Early Career Fellowship, Career Development Fellowship), has published >110 peer-reviewed journal articles, and she has been a keynote/invited speaker at >100 national and international conferences. Her research has won both national and international awards, including the World Congress of Pain Ronald Dubner Research Prize, the Australian Pain Society Rising Star Award and the Australian Physiotherapy Association Best New Investigator Award.
Her research explores the sensory and cognitive contributors to pain and spans discovery to clinical implementation. That is, her work aims to better understand how the experience of pain is created and to use this knowledge to develop and test novel brain-based treatments for pain. She investigates the sensory contributors (and neural underpinnings) of pain in a unique way – by manipulating our sense of reality. Using mediated and virtual reality, her work explores the contribution of multisensory input to the experience of pain and to the experiences of (and engagement in) effortful treatments such as exercise. She is also interested in the role that pain science education – specifically shifting how an individual conceptualises and understands pain – plays in recovery from chronic pain, with a focus on knee osteoarthritis. She has authored a book (EPIPHAKNEE) that provides contemporary pain science knowledge about osteoarthritis and its treatment for both people with osteoarthritis and their treating clinicians.
Tasha holds active roles in knowledge dissemination, science communication, and media engagement. She was recognised as one of Australia’s Top 5 under 40 Science Communicators (ABC Radio National and UNSW) and was the SA Tall Poppy of the Year in 2015. She is the founder of the Brain Bus – a mobile experiential lab that promotes knowledge transfer via real-world experiences. Through Pain Revolution (educational tour) – The Brain Bus has reached >5k people in rural and regional Australia. She has been featured on ABC’s Weekender, All in the Mind, Health Report, Catalyst, and Conversations with Sarah Kanowski.
You Might also like
-
Novel silk-based biomaterials for tissue engineering and regenerative medicine
Dr Jelena Rnjak-Kovacina is a Scientia Associate Professor and ARC Future Fellow leading a multidisciplinary group at the Graduate School of Biomedical Engineering, UNSW Sydney in Australia.
Her research interests are at the interface of biology and engineering, focusing on the development of biomimetic materials that direct cellular interactions for enhanced vascularisation and for the treatment of cardiovascular disease. In particular, she develops novel silk-based biomaterials and investigates how biomaterial properties translate to biological outcomes.
-
Dr Nischal Sahai
RESEARCH IN DEVICE TRIALS, VACCINE STUDIES, ORAL MEDICATIONS, INJECTABLES & INFUSIONS.
@ CLINICAL TRIAL CENTRE, UNIVERSITY OF THE SUNSHINE COAST
QUEENSLAND, AUSTRALIA -
Biological interactions of extracellular vesicles
Raluca Ghebosu graduated from the University of Queensland with a Bachelor of Arts/Bachelor of Science with majors in Japanese and Biomedical Science (2018-2021). She then completed her Bachelor of Science (Honours) with the School of Biomedical Sciences at the University of Queensland in 2022, before pursuing a PhD with A/Prof. Joy Wolfram at the Australian Institute for Bioengineering and Nanotechnology.